At present, I am participating in the implementation of Nanopore sequencing technology in Abriel’s group.
My background is in molecular biology with specialization in cloning and CRISPR technology. I am passionate about high-end technologies that give better understanding of biological processes. Therefore, I find Nanopore sequencing technology fascinating. By using patients’ genetic information, we are planning to: (1) determine the most suitable treatment (sickle cell disease, Haplotyping of HBB gene); (2) identify the impact of SLC30A2 mutation on the zinc concentration present in mother’s milk; and (3) help in establishing the diagnosis of cystic fibrosis for suspected patients.
In my spare time I enjoy discovering the wonders of Switzerland during hikes!
On the Web